These findings, combined with an upregulation of several genes involved in regulating whole-body insulin sensitivity and lipogenesis in subcutaneous fat in letrozole-treated rats, along with increased expression levels of several inflammatory factors and cytokines in letrozole-treated mice, indicate an adipose tissue dysfunction in the letrozole-exposed PCOS model (132, 228). Here, INS is linked to polycystic ovary syndrome.